Hyderabad: Pharma major Aurobindo Pharma on Wednesday said the US Food & Drug Administration (USFDA) has approved Ryzneuta (Efbemalenograstim alfa inj.
Ryzneuta for chemotherapy-induced neutropenia receives USFDA approval business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
Evive Biotech and Acrotech Biopharma Announce FDA Approval of Ryzneuta™ for ChemotherapyInduced Neutropenia equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
India Business News: Aurobindo Pharma has received approval from the US Food & Drug Administration (USFDA) for its long-acting Granulocyte colony-stimulating factor (G-CSF
The consensus of the advisory committee is that we have significant concerns about the very prolonged delay and getting these confirmatory studies underway.